Global and strategic regulatory affairs and new medicine development support
Total Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
51
NCT03202498
Safety and Tolerability of Yaq-001 in Patients With Cirrhosis
Phase: N/A
Role: Collaborator
Start: Feb 28, 2019
Completion: Mar 26, 2020
NCT03962608
Safety and Tolerability of Yaq-001 in Patients With Non-Alcoholic Steatohepatitis
Start: Jan 31, 2021
Completion: Jan 31, 2021
NCT05699083
Outcomes After Weight Loss Surgery in Low-Risk Patients
Role: Lead Sponsor
Start: Mar 11, 2022
Completion: Jan 12, 2026
Loading map...